Abstract
AbstractCannabinol (CBN), an incompletely understood metabolite for ∆9-tetrahydrocannabinol, has been suggested as an analgesic. CBN interacts with endocannabinoid (CB) receptors, but is also reported to interact with non-CB targets, including various ion channels. We assessed CBN effects on voltage-dependent sodium (Nav) channels expressed heterologously and in native dorsal root ganglion (DRG) neurons. Our results indicate that CBN is a functionally-selective, but structurally-non-selective Nav current inhibitor. CBN’s main effect is on slow inactivation. CBN slows recovery from slow-inactivated states, and hyperpolarizes steady-state inactivation, as channels enter deeper and slower inactivated states. Multielectrode array recordings indicate that CBN attenuates DRG neuron excitability. Voltage- and current-clamp analysis of freshly isolated DRG neurons via our automated patch-clamp platform confirmed these findings. The inhibitory effects of CBN on Nav currents and on DRG neuron excitability add a new dimension to its actions and suggest that this cannabinoid may be useful for neuropathic pain.
Funder
U.S. Department of Veterans Affairs
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Ghovanloo, M.-R. & Ruben, P. C. Cannabidiol and sodium channel pharmacology: general overview, mechanism, and clinical implications. Neuroscientist https://doi.org/10.1177/10738584211017009 (2021).
2. Morales, P., Hurst, D. P. & Reggio, P. H. Molecular targets of the phytocannabinoids: a complex picture. Prog. Chem. Org. Nat. Prod. 103, 103–131 (2017).
3. Maioli, C., Mattoteia, D., Amin, H. I. M., Minassi, A. & Caprioglio, D. Cannabinol: history, syntheses, and biological profile of the greatest ‘minor’ cannabinoid. Plants (Basel, Switzerland) 11, 2896 (2022).
4. Ghovanloo, M.-R., Dib-Hajj, S. D., Goodchild, S. J., Ruben, P. C. & Waxman, S. G. Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: an update on cannabidiol and cannabigerol. Front. Physiol. 13, 2379 (2022).
5. Jan, T. R., Farraj, A. K., Harkema, J. R. & Kaminski, N. E. Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. Toxicol. Appl. Pharmacol. 188, 24–35 (2003).